Literature DB >> 10840405

Focal cortical-subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent.

G Singh1, M S Sachdev, A Tirath, A K Gupta, G Avasthi.   

Abstract

PURPOSE: A focal cortical-subcortical calcification (FCSC) is a common finding on computed tomography (CT) in individuals with focal or generalized seizures in the Indian subcontinent. We sought to determine the relation of FCSCs to epilepsy by comparing the lobe of seizure origin by electroclinical and CT evaluations and to study the nature and severity of epilepsy associated with FCSCs.
METHODS: The relation of these FCSCs to epilepsy/seizures was studied in 40 patients, seen for the first time to the neurology outpatient department of a tertiary care hospital. An attempt was made to classify seizures and determine their lobe of origin based on clinical-electroencephalographic (EEG) criteria of the International League Against Epilepsy (ILAE). The clinical lobe of origin was compared with the location of the FCSC on CT scan. In addition, records of the CT unit of the same hospital were reviewed retrospecitvely, to identify cases with an FCSC and their referral diagnoses.
RESULTS: Thirty-one (77.5%) patients with FCSCs were considered to have localization-related epilepsy (frontal lobe epilepsy, 20; temporal lobe epilepsy, three; parietal lobe epilepsy, one; occipital lobe epilepsy, three; and definitely localization related but having ambiguous localization features, four) based on ictal semiology and EEG studies. Other ILAE categories in the cohort included epilepsy without unequivocal focal or generalized features (four patients; 10%), isolated seizures (one patient; 2.5%), juvenile absence epilepsy (one patient; 2.5%), and insufficient data to classify epilepsy (three patients; 7.5%). Radiologic sites for FCSCs included frontal (20; 50%), temporal (six; 15%), parietal (seven; 17.5%), and occipital (seven; 17.5%). Electroclinical and radiologic data were congruent in localizing and lateralizing seizures in 22 (55%) patients. The FCSC was truly incidental in one patient with juvenile absence epilepsy. Discordance between the clinical and radiologic localizations was noted in five (12.5%) instances. Magnetic resonance imaging (MRI) did not reveal additional lesions corresponding to lobes of origin as determined by electroclinical analysis. Discordance was surmised to be a result of seizure spread from a silent region to symptomatic cortex. In 12 (30%) patients, electroclinical and radiologic congruence could not be ascertained because ictal descriptions were either inadequate or ambiguous, and EEG findings were noncontributory. Review of 4,452 CT scans of brain performed in the CT unit revealed 29 (0.65%) cases with FCSCs in individuals with nonseizure disorders, that could be labeled as incidental.
CONCLUSIONS: An FCSC is an important radiologic finding in localization-related epilepsy in the Indian subcontinent. The severity of epilepsy ranges from asymptomatic cases to daily seizures.

Entities:  

Mesh:

Year:  2000        PMID: 10840405     DOI: 10.1111/j.1528-1157.2000.tb00234.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.

Authors:  Winnie W Ooi; Subhashie Wijemanne; Christine B Thomas; Martha Quezado; Charles R Brown; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

2.  Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.

Authors:  Gan You; Zhi-Yi Sha; Wei Yan; Wei Zhang; Yong-Zhi Wang; Shao-Wu Li; Lin Sang; Zi Wang; Gui-Lin Li; Shou-Wei Li; Yi-Jun Song; Chun-Sheng Kang; Tao Jiang
Journal:  Neuro Oncol       Date:  2011-12-19       Impact factor: 12.300

Review 3.  Disease Centered Around Calcified Taenia solium Granuloma.

Authors:  Theodore E Nash; Javier A Bustos; Hector H Garcia
Journal:  Trends Parasitol       Date:  2016-10-04

Review 4.  Calcific neurocysticercosis and epileptogenesis.

Authors:  T E Nash; O H Del Brutto; J A Butman; T Corona; A Delgado-Escueta; R M Duron; C A W Evans; R H Gilman; A E Gonzalez; J A Loeb; M T Medina; S Pietsch-Escueta; E J Pretell; O M Takayanagui; W Theodore; V C W Tsang; H H Garcia
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

Review 5.  Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment.

Authors:  Theodore Nash
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

6.  Natural History of Patients With Perilesional Edema Around Taenia solium Calcified Granulomas.

Authors:  Theodore E Nash; JeanAnne M Ware; Siddhartha Mahanty
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

7.  Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study.

Authors:  Mateus de Oliveira Taveira; Marcia Elisabete Morita; Clarissa Lin Yasuda; Ana Carolina Coan; Rodrigo Secolin; Alberto Luiz Cunha da Costa; Fernando Cendes
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

8.  Epilepsy surgery in context of neurocysticercosis.

Authors:  Gagandeep Singh; Ashwani Kumar Chowdhary
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

9.  Toll-like Receptor-4 Polymorphisms and Serum Matrix Metalloproteinase-9 in Newly Diagnosed Patients With Calcified Neurocysticercosis and Seizures.

Authors:  Gaurav Lachuriya; Ravindra Kumar Garg; Amita Jain; Hardeep Singh Malhotra; Arvind Kumar Singh; Bhawna Jain; Neeraj Kumar; Rajesh Verma; Praveen Kumar Sharma
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

10.  Topographic congruence of calcified parenchymal neurocysticercosis and other structural brain lesions with epileptiform activity.

Authors:  Erin K Saito; Meera Nagpal; Amanda Leon; Bijal Mehta; Aaron Matthew McMurtray
Journal:  Trop Parasitol       Date:  2016 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.